1 We investigated the effects of rotigaptide (ZP123), a stable hexapeptide with antiarrhythmic properties, on gap junction mediated intercellular communication in contracting rat neonatal cardiac myocytes, HL-1 cells derived from cardiac atrium and in HeLa cells transfected with cDNA encoding Cx43-GFP, Cx32-GFP, Cx26-GFP, wild-type Cx43 or wild-type Cx26. 2 Intercellular communication was monitored before and after treatment with rotigaptide following microinjection of small fluorescent dyes (MWo1 kDa). The communication-modifying effect of rotigaptide was confined to cells expressing Cx43 since the peptide had no effect on dye transfer in HeLa cells expressing Cx32-GFP, Cx26-GFP or wild-type Cx26. In contrast, HeLa cells expressing Cx43-GFP exposed to 50 nM rotigaptide for 5 h showed a 40% increase in gap junction mediated communication.
Introduction
Direct communication across gap junctions facilitates the functional coordination of cell networks (Loewenstein, 1981) . Modifying the extent of cell to cell signalling across gap junction channels is likely to disrupt the synchronisation of individual activities of constituent cells in tissues and organs. Remodelling of gap junctions and changes in intercellular communication via these channels are associated with a number of pathophysiological conditions including ischaemia, cardiac arrhythmia, hypertension and atherosclerosis, as well as endothelial and epithelial wound healing events (Saez et al., 2003; Rummery & Hill, 2004; Severs et al., 2004) . Connexins, the protein subunits assembled into gap junction intercellular channels, are therefore emerging as therapeutic targets (Dhein, 2004) .
In the heart, gap junctions couple myocytes electrically and mechanically ensuring intercellular propagation of action potentials as well as Ca 2 þ waves, communication processes that underpin synchronous contraction at the cellular and organ level (Kleber & Rudy, 2004) . To address cardiac arrhythmia, hexa-peptides such as AAP10 derived from bovine atria and a stable analogue ZP123, now termed rotigaptide, have been developed to modify gap junctional channel properties and intercellular communication (Muller et al., 1997; Dhein et al., 2003) . Rotigaptide promoted electrical coupling between ventricular myocytes without changing membrane conductance (Xing et al., 2003) . The peptide attenuated gap junction closure and preserved intercellular coupling during acidosis (Eloff et al., 2003; Kjolbye et al., 2003; Xing et al., 2003; Haugan et al., 2005) . Most importantly, rotigaptide reduced the inducibility of re-entry ventricular tachycardia during acute ischaemia in dogs (Xing et al., 2003) . Indeed, these properties suggest that rotigaptide could be a prototype of a new class of antiarrhythmic drug. Connexins are a highly conserved 20 member family of membrane proteins that assemble into dodecameric gap junction channels (Willecke et al., 2002) . All connexins share a common topology, traversing the lipid bilayer four times with two highly conserved extracellular loops. The carboxyl terminus is located intracellularly and varies in sequence and length between the different connexins (Evans & Martin, 2002) . The carboxyl tail of Cx43 is subject to post-translational phosphorylation (Lampe & Lau, 2004) , the extent of which is dynamically regulated and appears to influence channel permeability (Harris, 2001) . Cells in most tissue express different combinations of connexins. Connexin 43 is the dominant connexin expressed in mammalian heart. It is also highly expressed in many other tissues including skin where Cx26 and up to 10 other connexins are also differentially expressed in the dermal cell layers (Di et al., 2001; Willecke et al., 2002) . Cx32 is found in several tissues including the nervous system and liver (Willecke et al., 2002) . Each connexin subtype has distinctive permeability properties with different connexins exhibiting differing abilities to transfer small fluorescent marker dyes of varying molecular mass to neighbouring cells. For example, Cx43 gap junctions are permeable to most molecules o1 kDa in size. By contrast, Cx26 gap junctions are more selective and are permeable to small dyes such as Lucifer yellow (MW 457 Da) but are impermeable to larger marker dyes such as Alexa594 (MW 780 Da) (Nicholson et al., 2000) . Differences in the permeabilities of Cx26, Cx32 and Cx43 channels to secondary messengers including cAMP, adenosine and IP3 have also been reported (Niessen et al., 2000; Harris, 2001; Goldberg et al., 2002) . Such properties are believed to reflect specific physiological requirements of different tissues. The dynamic role that connexin membrane channels play in various physiological and pathophysiological conditions makes agents that target gap junctional communication potentially useful therapeutic tools.
In the present study, we investigated the effects of rotigaptide on the functionality and protein expression profiles of Cx43 channels in three model systems; rat neonatal cardiac myocytes, HL-1 cells (Claycomb et al., 1998) and HeLa cells transfected and selected to express different connexins. The lack of effect of rotigaptide on the permeability of Cx32-GFP and Cx26 gap junctions in HeLa cell model systems allowed the connexin specificity of rotigaptide action to be examined.
Methods

Preparation and culture of primary rat neonatal myocytes
Hearts from fifty 2 to 5-day-old Wistar rats were harvested, minced and single cells dissociated by serial trypsin treatment (Webster et al., 1999) . After trypsin digestion, cells were washed and preplated for 1 h in Dulbecco's modified essential medium (DMEM), supplemented with 5% foetal calf serum (FCS) and penicillin/streptomycin (P/S) (100 mg ml
À1
). Nonattached cells were replated in 60 mm tissue culture dishes (Greiner bio-one, Germany) at 4 Â 10 6 cells/dish in the same medium as outlined above, supplemented with 0.1 mM bromodeoxyuridine (BrDu). After 4 days, cells were transferred to serum-free DMEM supplemented with P/S (100 mg ml À1 ), BrDu (0.1 mM), vitamin B 12 (1.5 mM) and insulin (20 mg ml
). Cells (495% myocytes) were used after 5-7 days. The preplating step and BrDu supplementation ensured the background of nonmyocardial cells (mainly fibroblasts) was minimal. The resultant cultures of rat neonatal cardiac myocytes contracted synchronously at 4100 beats min À1 (bpm).
Cell culture
HL-1 atrial cardiomyocytes were maintained in Claycomb medium, supplemented with 10% FCS, P/S (100 mg ml
À1
), epinephrine (0.1 mM) and L-glutamine (2 mM) as previously described (Claycomb et al., 1998) . HeLa cells selected to express Cx43-GFP, Cx32-GFP or Cx26-GFP were prepared as described (Paemeleire et al., 2000) and maintained in DMEM, supplemented with 10% FCS, P/S (100 mg ml À1 ), amphotericin (100 mg ml À1 ), L-glutamine (2 mM) and geneticin sulphate (G-418-sulphate 4 mg ml
). HeLa cells expressing wild-type Cx26 or Cx43 were maintained in cDMEM supplemented with 0.5 mg ml À1 puromycin (Elfgang et al., 1995) .
Dye transfer across gap junctions
Rat neonatal cardiac myocytes and HeLa cells were seeded at a density of 4 Â 10 6 cells per 60 mm dish and 1 Â 10 6 cells per 60 mm dish, respectively. Cx-GFP protein expression in HeLa cells was enhanced by addition of 5 mM sodium butyrate to the medium 18 h prior to the experiments (George et al., 1998 .
Cell cytometric analysis
HeLa cells expressing Cx43-GFP were plated onto six-well dishes (1 Â 10 5 cells) and were exposed to 50 or 250 nM rotigaptide for periods of 1 or 5 h. Cells were harvested by trypsinisation, washed in PBS and resuspended to a final concentration of 1 Â 10 6 ml
À1
. Cells (1 Â 10 5 ) were added to 500 ml of fluorescent activated cell sorting (FACS) sheath fluid (Becton Dickson, CA, U.S.A.) and subjected to FACS analysis after excitation at 488 nm. Data was exported to a Microsoft Excel spreadsheet and analysed. Experiments were repeated three times and data presented as mean7s.e.m.
Western blot analysis
Cells grown on 60 mm dishes (4 Â 10 6 rat neonatal cardiac myocytes; 1 Â 10 6 HeLa cells) were treated for periods of 1 to 5 h with 50, 100 or 250 nM rotigaptide, or 25 mM 18 a-glycyrrhetinic acid (18aGA) prior to harvesting in 200 ml of ice-cold lysis buffer (1% w v À1 SDS, 1 mM DTT, 1 mM sodium orthovanadate, 4 ng ml À1 leupeptin, 4 ng ml À1 apoprotinine and 1 mM phenylmethylsulphonyl fluoride in PBS), followed by sonication. Equal amounts of protein (100 mg rat neonatal cardiac myocyte lysates; 50 mg HeLa cell lysates) were analysed by SDS-PAGE (10% w v
À1
) and transferred onto nitrocellulose in transfer buffer (20 mMNa 2 CO 3 ) for 3 h at 300 mA. The transfer efficiency was assessed by Ponceau
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Connexin specifity of rotigaptide (ZP123) S staining of the blots prior to further probing with a polyclonal antibody to Cx43 (1 : 4000 dilution) that recognises multiple phosphorylated/nonphosphorylated isoforms of Cx43 and a secondary goat anti-rabbit horseradish peroxidase antibody (1 : 2000 dilution). In some experiments, blots were also probed with a polyclonal antibody that recognises sitespecific phosphorylation of serine 368 on the carboxyl tail of Cx43 (1 : 1000 dilution). To standardise protein expression, blots were also probed with a monoclonal antibody to a-tubulin (1 : 10 000 dilution) and a secondary goat anti-mouse horseradish peroxidase antibody (1 : 2000 dilution). Blots were developed by enhanced chemiluminescene (ECL) and quantified using a Biorad GS-700 densitometer .
Connexin 43 phosphorylation assays
Protein extracts (30 mg) were digested with 60 U of calf intestinal phosphatase for 1 h at 371C and analysed by SDS-PAGE and Western blotting as described above. In some experiments, cells were treated with 100 ng ml À1 TPA (12-Otetradecanoylphorbol 13-acetate), a protein kinase C activator, for 30 min prior to harvesting the cells to serve as a positive control when analysing serine 368 phosphorylation of Cx43.
Materials
DMEM, supplements for cell growth and other tissue culture reagents were supplied by Invitrogen (Glasgow, U.K.). G418-sulphate and Calf Intestinal Phosphatase were purchased from Promega, (Southhampton U.K.) and Lucifer yellow, Alexa-488, Alexa-594 were obtained from Molecular Probes (Leiden, The Netherlands). The Cx43 monoclonal and P368 antibodies were obtained from Chemicon (Chandlers Ford, U.K.). Other connexin antibodies for Western blotting were obtained from Zymed (Cambridge, U.K.). The goat anti-mouse and rabbit horseradish peroxidase were supplied by BioRad (Hemel Hempsted, U.K.) and the ECL system from Pierce (Tattenhall, U.K.). Rotigaptide was supplied by Zealand Pharma and dissolved in water to give a 50 mM stock and 18 aGA was dissolved in DMSO to give a 25 mM stock. All other reagents were obtained from Sigma (Poole, U.K.).
Statistical analysis
Data were evaluated by ANOVA followed by Dunnett's multiple comparison test, with Po0.05 being considered significant. Table 1 ). Although a slight increase in coupling was also observed following treatment with 100 nM rotigaptide this was not significant (Table 1) . There was no further modification of dye spread at these increased doses, suggesting that 50 nM is the optimal concentration at which rotigaptide operates in this system or that any further enhancement is not readily distinguished by monitoring spread of dye.
Results
Rotigaptide increases gap junctional communication in rat neonatal cardiac myocytes
To demonstrate that intercellular transfer of dye occurred across gap junctions, cells were treated with 18 aGA for 1 h prior to microinjection and following exposure to 50 nM rotigaptide for 5 h (Figure 1a ). Dye transfer was totally blocked under both conditions (Table 1 ). These results suggest that rotigaptide does not offset the effects of 18 aGA, a putative gap junction uncoupler (Davidson & Baumgarten, 1988) . Despite the increase in intercellular coupling elicited by rotigaptide, the peptide had no significant effect on beating rates and their synchronicity in cardiac myocytes, which was maintained at approximately 150 bpm during each of the drug treatments ( Figure 1d ). 
Rotigaptide increases gap junctional communication
The connexin specificity of rotigaptide
Untransfected HeLa cells are communication incompetent and do not transfer dyes to neighbouring cells (Elfgang et al., 1995; George et al., 1998) . HeLa cells were made communication competent by transfection and selection of variants expressing Cx43-GFP, Cx32-GFP or Cx26-GFP, or wild-type Cx43 or Cx26. Following induction of Cx43-GFP expression with sodium butyrate, 37.978.2% of the transfected cells transferred dye to X5 neighbours confirming previous results (Martin et al., 2001) (Figure 3 , Table 1 ). Time course experiments, pursued to analyse the effects of rotigaptide (50 nM) on the efficiency of gap junctional coupling, showed that 2-3 h incubation with the peptide was without significant effect on the intercellular spread of Lucifer yellow (Figure 3a) . However, after 5-6 h incubation with the peptide, increased dye transfer was observed, although overnight incubation did not result in further dye spread (Table 1) . Similar findings were also observed with HeLa cells expressing wild-type Cx43, where preincubation with 50 nM rotigaptide for 5 h enhanced the spread of Alexa-594 to neighbouring cells (data not shown). Dye transfer was significantly reduced following preincubation of the cells with 18 aGA for 1 h prior to microinjection of dye under control conditions and following 5 h rotigaptide (50 nM) treatment; a similar result was obtained with cardiac myocytes (data not shown).
To determine if rotigaptide had any selectivity on the molecular mass of molecules transferred the intercellular spread of Lucifer yellow (charge À2, MW 457 Da) and Alexa-594 (chargeÀ1, MW 758 Da) was compared in HeLa 488
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Connexin specifity of rotigaptide (ZP123) cells expressing Cx43-GFP. Lucifer yellow was found to diffuse more efficiently through Cx43-GFP gap junctions than Alexa-594, with 37.978.2% of cells transferring Lucifer yellow whereas only 971.24% of cells transferred Alexa-594 to X5 neighbouring cells, respectively. Transfer of both dyes increased significantly after 5 h treatment with rotigaptide (50 nM) ( Figure 3b , Table 1 ). In general, Cx43-GFP channels transferred Lucifer yellow to a greater number of cells than Alexa-594, attributed to the increased MW of Alexa-594 and its lower transfer efficiency in control cells. Interestingly, the upregulation of dye transfer by rotigaptide was greater for Alexa594 than Lucifer yellow (Table 1) . HeLa cells expressing Cx32-GFP and Cx26-GFP exhibited lower dye coupling efficiency than Cx43-GFP transfected HeLa cells, with 37.373.4% of Cx32-GFP expressing cells transferring Lucifer yellow to X3 neighbouring cells ( Figure 3c , Table 1 ). This is a characteristic of these selected cell lines that may be related to the level of Cx expression in the cells. However, incubation with 50 nM rotigaptide for 5 h had no significant effect on the extent of Lucifer yellow transfer.
Furthermore, increasing the dose of rotigaptide to 100 or 250 nM rotigaptide caused no significant change in dye transfer. Similar results were obtained with Cx26-GFP expressing cells (Figure 3d ). Rotigaptide had no significant effect on the extent of transfer of Alexa 488 (charge À1, MW 570) in HeLa cells expressing wild-type Cx26 following 5 h incubation with 50 nM Rotigaptide, further confirming the lack of effect of rotigaptide on Cx26 (Table 1 ). Previous studies show that dye transfer properties of Alexa 488 and Lucifer yellow are very similar (Martin et al., 2005; Nicholson et al., 2000 unpublished observations) . By contrast, Cx26 wild-type expressing cells were unable to efficiently transfer Alexa 594 (Martin et al., 2005; Nicholson et al., 2000; unpublished observations) .
Effects of rotigaptide on connexin43-GFP expression levels
The inherent autofluorescent properties of Cx43-GFP permitted analysis of the effect of rotigaptide on Cx43-GFP Figure 1 The effect of rotigaptide and 18 aGA on Alexa-488 transfer and cell beating rate in rat neonatal cardiac myocytes. 
Effects of rotigaptide on connexin43 expression profiles in rat neonatal cardiac myocytes and connexin43 transfected HeLa cells
Immunoblot analysis of rat neonatal cardiac myocytes confirmed that Cx43 migrated electrophoretically as two phosphorylated forms (P1 and P2 bands; 43-45 kDa), with a minor band at 41 kDa (Figure 5a ). Under control conditions Cx43-GFP migrated at B70 kDa and its intensity increased following 18-24 h treatment with sodium butyrate, that is, at times when dye transfer studies were performed (Figure 6a) . A further band, at B81 kDa was confirmed as a phosphorylated isoform of Cx43-GFP in these cells (Figure 6a ) since the chimera was dephosphorylated by alkaline phosphatase treatment. Similarly, Cx43 in rat neonatal cardiac myocytes also showed a 41 kDa band that was likely to be a nonphosphorylated form of Cx43 (Figure 5a ), consistent with previous reports (Beardslee et al., 2000) . Parallel data from HeLa cells expressing wild-type Cx43 gave similar results (data not shown). Rat neonatal cardiac myocytes treated with 50, 100, and 250 nM rotigaptide for 1 or 5 h showed little change in Cx43 phosphorylation status using an antibody that recognises multiple phosphorylated isoforms of Cx43 (Beardslee et al., 2000) (Figure 5b ). Densitometric analysis of the gels confirmed that there was no significant difference between the phosphorylation status of Cx43 under control conditions or rotigaptide treatment detected by this antibody (Figure 5c ).
The effect of rotigaptide on the phosphorylation status and expression of Cx43-GFP in HeLa cells was studied. After 
490
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Connexin specifity of rotigaptide (ZP123) treatment with rotigaptide (50-250 nM) for 5 h, the phosphorylation status and level of Cx43-GFP expression remained unaltered (Figure 6c and d) . However, preincubation of cells with the gap junction inhibitor 18 aGA reduced the phosphorylation of Cx43-GFP ( Figure 6b) ; phosphorylation of Cx43 was similarly reduced following incubation with 18 aGA in the rotigaptide treated cells (Figure 6b ). Rotigaptide is reported to stimulate protein kinase C (Dhein et al., 2003) and it is possible that the antibodies used in the current work failed to detect significant changes in phosphorylation at specific sites. We therefore investigated the effects of rotigaptide on Cx43 expression using an antibody specifically recognising the Ser368 phosphorylation site that is reported to be phosphorylated by protein kinase C . Treatment of cells with TPA, a potent activator of protein kinase C , confirmed that phosphorylation of Cx43 and Cx43-GFP at position ser368 occurred (Figure 7b and c). HeLa cells expressing wild-type Cx43 under control conditions, following TPA treatment and 5 h treatment with 50 nM rotigaptide were also probed with another antibody that detects multiple Cx43 isoforms (Rivedal et al., 1996) . In both cases, there was no indication of alteration in the amount of Cx43 expressed following rotigaptide treatment, but it was noted that substantial phosphorylation occurs following TPA treatment (Figure 7a and b) . Similar results were also obtained for Cx43 analysed from cardiac myocytes (data not shown). 
Connexin specifity of rotigaptide (ZP123)
Discussion
We studied the specificity and effects of rotigaptide, an antiarrhythmic peptide, on intercellular communication across gap junctions in HeLa cell model systems and in cardiospecific cells. In heart, gap junctions provide low resistance intercellular channels that facilitate synchronous contraction of the myocytes (Kleber & Rudy, 2004) . Since disturbed myocardial coupling is implicated in arrhythmogenesis (Xing et al., 2003; Severs et al., 2004) , it is likely that drugs that modulate the extent of inter-myocyte communication via gap junctions may influence synchronisation and rhythmicity of contraction in the myocardium. The mechanism of action of such drugs should reveal new therapeutic approaches to understanding and correcting arrhythmia. Rotigaptide is a stable analogue of the antiarrhythmic peptide AAP10 (Muller et al., 1997) , its increased stability allowing protracted action by the use of D-amino acids that are less prone to degradation by proteases than L-amino acids. Rotigaptide has an in vitro half-life in human plasma of 14 days compared to 3-4 min for AAP10 . Previous studies have shown that AAP10 enhanced conductance in adult cardiac myocytes and in HeLa cells expressing Cx43 (Dhein et al., 2001) . Rotigaptide prevented re-entrant ventricular tachycardia during myocardial ischaemia in dogs (Xing et al., 2003) . Although the effects of rotigaptide on cardiac electrophysiology and Cx43 mediated communication have been studied (Dhein et al., 2003; Eloff et al., 2003) , its influence on other functional properties of gap junctions have not been investigated. Optimal doses of rotigaptide in these studies, were determined to be between 50 and 100 nM. In the present studies, we found that increasing the dose to 100 or 250 nM had no further enhancement of action.
The present results show that rotigaptide increased gap junctional intercellular communication in cells expressing Cx43 as monitored by the direct intercellular transfer of fluorescent dyes of different molecular mass. This increased communication was demonstrated in HeLa cells expressing wild-type Cx43 and Cx43-GFP, but was not observed in HeLa cells expressing wild-type Cx26, Cx26-GFP or Cx32-GFP. Although some connexins used in the present work were fused to GFP at its carboxyl terminus, HeLa cells expressing Cx43-GFP, Cx32-GFP and Cx26-GFP were shown previously to be electrically and dye coupled and to propagate intercellular Ca 2 þ waves to each other via gap junctions or connexin hemichannels (Bukauskas et al., 2000; Contreas et al., 2002) . Fluorescent and nonfluorescent wild-type Cx43 expressing channels show similar functional characteristics in a variety of cell types, although subtle differences in channel gating have been reported (Bukauskas et al., 2000; Paemeleire et al., 2000) . The present studies show that rotigaptide acts on both wild type and chimeric Cx43 but not on wild type or chimeric Cx26 channels or on chimeric Cx32 channels. Increased intercellular dye coupling was also observed in beating neonatal cardiac myocytes and a cell line derived from cardiac atria that possesses many cardio-specific properties (Claycomb et al., 1998) . Cx43 is the dominant gap junction protein in both Figure 4 The effect of rotigaptide on Cx43GFP expression. Cx43-GFP expressing HeLa cells were subject to FACS analysis and the % of cells expressing Cx43-GFP recorded following treatment for 1 and 5 h with 50 and 250 nM rotigaptide, respectively. 
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Connexin specifity of rotigaptide (ZP123) cell types (unpublished data). The enhancing effect on Cx43 dye coupling via gap junctions occurred after 5 h exposure to rotigaptide in a concentration independent manner. In contrast, the accelerated transmission of electrical signals following rotigaptide treatment was observed within 15 min using isolated guinea pig ventricular myocytes and rat atrial strip preparations (Xing et al., 2003; Haugan et al., 2005) . These differences in the speed of action suggest that rotigaptide may firstly act rapidly on electrical coupling across gap junctions followed by an increase in the spread of larger molecules across the junctions and further support observations that dye movement and electrical communication via gap junctions are not always causally related. Despite the enhanced propagation of dye now reported and the increase in electrical coupling (Eloff et al., 2003; Haugan et al., 2005) , rotigaptide had no effect on the overall synchronisation and contraction rate of the cardiac myocytes and the spatial localisation of Cx43 in cells was unaltered. Furthermore, even after exposure of cells to rotigaptide for 5 h the overall expression level of Cx43 in the HeLa cell model nor in neonatal cardiac myocytes was unchanged, suggesting that up to this time point rotigaptide is not affecting the dynamics of Cx43 life cycle . Exposure of cells for 30 min to AAP10 and rotigaptide has been associated with enhanced protein kinase C activity in HeLa cells expressing Cx43, suggesting that rotigaptide may be phosphorylating Cx43 via a protein kinase C-dependent mechanism associated with enhanced electrical communication, and these studies implicated a 200 kDa plasma membrane protein (Weng et al., 2002; Dhein, 2004) . However, these studies did not address Cx43 phosphorylation specifically. Phosphorylation of Cx43 has been associated with the control of gap junction mediated communication during connexin biogenesis and degradation (Laird, 2005) and in the response of cardiac myocytes to normoxia and hypoxia (Lampe & Lau, 2004; Turner et al., 2004) . Activation of PKC results in phosphorylation of several serine sites including Ser368 and Ser 262 located on the carboxyl terminal tail of Cx43 (Lampe & Lau, 2004) . However, no detectable changes in the phosphorylation status of Cx43 were observed following rotigaptide treatment by Western blot analysis, examined using a variety of antibodies that detect multiple Cx43 phosphorylated isoforms or a specific protein kinase C phosphorylation site (Serine, 368) . Control experiments using the phorbol ester TPA, a potent inducer of protein kinase C , showed that Cx43-GFP is subject to protein kinase C dependent phosphorylation at serine 368 further demonstrating that the attached GFP reporter protein does not modify normal Cx43 function. To ultimately determine whether rotigaptide specifically modulates the phosphorylation status of Cx43 on any of the multiple phosphorylation sites of the carboxyl terminus may require other techniques such as mass spectrometry, which would help to elucidate a concise mechanism of action of this peptide. It is also noteworthy that the Cx26-GFP and Cx32-GFP expressing HeLa cells were unaffected by rotigaptide and that these connexins are either not phosphorylated or are subject to minor phosphorylation (Lampe & Lau, 2004) . Another potential, yet unexplored mechanism of action of rotigaptide action, is the effect it may have on Cx43 hemichannel function. The present experiments were performed under normal conditions of CO 2 , O 2 and nutrient supply. It is possible that further mechanistic effects of rotigaptide are apparent under conditions of cell stress such as ischemia and those mimicking arrhythmia where further modifications of Cx43 by rotigaptide may be apparent and is subject to further investigation.
Intercellular communication across gap junctions in cells expressing various connexins, including homotypic Cx43, 32 and 26, have been extensively studied electrophysiologically (Harris, 2001) and by dye coupling (Elfgang et al., 1995; Cao et al., 1998) . These studies have shown that connexin channels show differential permeabilities to a range of dyes of differing 
Connexin specifity of rotigaptide (ZP123) charge and MW, including those currently studied. The present data indicate that rotigaptide selectively influences homotypic gap junctions constructed of Cx43, but is without effect on gap junctions constructed of Cx26 and 32. It should be noted that the extent of enhancement of dye spread by rotigaptide through Cx43 channels may be underestimated due to the limits of detection of the system as the dye spreads from the injected cell to neighbouring cells. Indeed, the detection limits also vary with individual dyes depending on their quantum yield and rates of photobleaching. Such differences in the nature of the fluorescent probes and molecule transfer rates may also partly explain the enhanced transfer of the larger Alexa 594 compared to Lucifer yellow following rotigaptide treatment. Further differences on the effect of rotigaptide on molecule transfer will only be resolved by analysing the direct rates of dye spread by timelapse microscopy and rate kinetic analysis. The present data show that rotigaptide enhances the spread of dyes of differing molecular mass, with there being preferential enhancement of transfer of larger sized molecules and suggest that the nature of molecule transfer may be an important aspect of the mechanism of rotigaptide action. The highly specific effect of rotigaptide on gap junction intercellular communication is further supported by radioligand binding assays in which rotigaptide displayed only weak binding affinity to 80 different receptors and ion channels (Haugan et al., 2005) . Further analysis of the selective action of rotigaptide on connexins, to supplement electrophysiological studies in cardiac tissue (Eloff et al., 2003) , is expected to elucidate the biochemical mechanisms that result in the action of rotigaptide occurring at Cx43 gap junctions but not on junctions constructed of Cx26 and Cx32. The effects of rotigaptide on other connexins associated with the cardiovascular system (Cx40 and Cx45) remain to be explored.
The emergence of rotigaptide as an enhancer of intercellular communication across gap junctions constructed of Cx43 supports the view that it is a useful reagent to develop further as a therapeutic tool for modulating acute cardiac arrhythmias. 
